# Treatment of Cerebral Arteriovenous Malformations With SQUID Liquid Embolic Agent (CHOICE)

> **NCT03413852** · — · UNKNOWN · sponsor: **Embo-Flüssigkeiten A.G.** · enrollment: 111 (actual)

## Conditions studied

- Cerebral Arteriovenous Malformation

## Interventions

- **DEVICE:** SQUID non-adhesive liquid embolic agent

## Key facts

- **NCT ID:** NCT03413852
- **Lead sponsor:** Embo-Flüssigkeiten A.G.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-05-11
- **Primary completion:** 2022-03
- **Final completion:** 2022-08
- **Target enrollment:** 111 (ACTUAL)
- **Last updated:** 2021-04-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03413852

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03413852, "Treatment of Cerebral Arteriovenous Malformations With SQUID Liquid Embolic Agent (CHOICE)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03413852. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*